Development of treatment-decision algorithms for children evaluated for pulmonary tuberculosis: an individual

Kenneth S Gunasekera1, Olivier Marcy2, Johanna Muñoz3

  • 1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.

Insights

New algorithms improve diagnosis of childhood tuberculosis (TB). These evidence-based tools aid treatment decisions in primary care, aiming to reduce mortality in high-incidence areas.

Area of Science:

  • Global Health
  • Infectious Diseases
  • Pediatrics

Background:

  • Pulmonary tuberculosis (TB) in children often goes undiagnosed, leading to high morbidity and mortality.
  • Existing diagnostic algorithms for childhood TB are limited in generalizability.
  • There is a need for improved, evidence-based algorithms for TB treatment decisions in primary care settings.

Approach:

  • A meta-analysis of individual participant data from 13 studies across 12 high-TB-incidence countries was conducted.
  • Two multivariable prediction models were developed: one including chest X-ray features and one using only clinical features.
  • These models were used to create pragmatic, evidence-based treatment-decision algorithms for primary healthcare.

Key Points:

  • Existing algorithms showed variable diagnostic performance.
  • The model incorporating clinical and chest X-ray features achieved a sensitivity of 0.86 and specificity of 0.37.
  • The model using only clinical features had a sensitivity of 0.84 and specificity of 0.30.

Conclusions:

  • Developed algorithms empower healthcare workers to initiate TB treatment in children, improving access to care.
  • These algorithms are designed for primary care settings in high-incidence areas, regardless of resource availability.
  • The algorithms aim to reduce childhood TB-related mortality and have been incorporated into WHO guidelines.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
221
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
185
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
289
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
295
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
394
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
322